| Financial Year |
March 31 2023 |
| Monetary Funds |
186,539,256.51 |
| Held-for-trading Financial Assets |
482,396,638.56 |
| Notes Receivable |
2,644,465.62 |
| Accounts Receivable |
165,087,803.90 |
| Advances to Suppliers |
5,331,315.26 |
| Other Receivables |
1,262,324.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,250,141.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
386,374,860.65 |
| Total Current Assets |
1,241,847,638.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,021,448,977.14 |
| Under-construction Projects |
327,549,405.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
549,806,658.55 |
| R&D expenses |
1,334,841.51 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,833,873.19 |
| Deferred Income Tax Assets |
66,008,173.45 |
| Other Non-Current Assets |
3,075,076.24 |
| Sub-Total of Non-Current Assets |
1,972,622,111.48 |
| Total Assets |
3,214,469,749.93 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
142,390,019.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,539,284.54 |
| Taxes Payable |
11,770,952.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,872,208.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
207,009.56 |
| Sub-Total of Current Liabilities |
189,966,270.79 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
266,546,614.72 |
| Total Liabilities |
456,512,885.51 |
| Paid-In Capital(Or Share Stock) |
1,322,400,000.00 |
| Capital Surplus |
1,120,348,273.56 |
| Surplus Reserve |
33,800,156.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
281,408,434.11 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,757,956,864.42 |
| Owner's Equity（Stockholder's Equity） |
2,757,956,864.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,214,469,749.93 |
